Found: 60
Select item for more details and to access through your institution.
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [In-DOTA]MG11-first estimates for clinical translation.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-015-0158-3
- By:
- Publication type:
- Article
[In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study.
- Published in:
- EJNMMI Research, 2012, v. 2, n. 1, p. 1, doi. 10.1186/2191-219X-2-25
- By:
- Publication type:
- Article
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.
- Published in:
- Molecules, 2020, v. 25, n. 15, p. 3418, doi. 10.3390/molecules25153418
- By:
- Publication type:
- Article
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair.
- Published in:
- Molecules, 2019, v. 24, n. 6, p. 1015, doi. 10.3390/molecules24061015
- By:
- Publication type:
- Article
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [<sup>67</sup>Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.
- Published in:
- Molecules, 2017, v. 22, n. 11, p. 1950, doi. 10.3390/molecules22111950
- By:
- Publication type:
- Article
Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 2, p. 318, doi. 10.2967/jnumed.107.045054
- By:
- Publication type:
- Article
MicroPET Imaging of Gene Transfer with a Somatostatin Receptor--Based Reporter Gene and <sup>94m</sup>Tc-Demotate 1.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 11, p. 1889
- By:
- Publication type:
- Article
CCK-2/Gastrin Receptor--Targeted Tumor Imaging with <sup>99m</sup>Tc-Labeled Minigastrin Analogs.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 10, p. 1727
- By:
- Publication type:
- Article
Species Differences of Bombesin Analog Interactions with GRP-R Define the Choice of Animal Models in the Development of GRP-R--Targeting Drugs.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 5, p. 823
- By:
- Publication type:
- Article
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1921, doi. 10.3390/ijms25031921
- By:
- Publication type:
- Article
Side-Chain Modified [ 99m Tc]Tc-DT1 Mimics: A Comparative Study in NTS 1 R-Positive Models.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15541, doi. 10.3390/ijms242115541
- By:
- Publication type:
- Article
[ 68 Ga]Ga-DATA 5m -LM4, a PET Radiotracer in the Diagnosis of SST 2 R-Positive Tumors: Preclinical and First Clinical Results.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14590, doi. 10.3390/ijms232314590
- By:
- Publication type:
- Article
Optimizing the Profile of [ 99m Tc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 7926, doi. 10.3390/ijms21217926
- By:
- Publication type:
- Article
[[sup 99m] Tc]Demotate, a new [sup 99m] Tc-based [Tyr[sup 3] ]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 6, p. 742, doi. 10.1007/s00259-002-0782-9
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
<sup>68</sup>Ga/<sup>177</sup>Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 2, p. 293, doi. 10.2967/jnumed.116.176636
- By:
- Publication type:
- Article
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 75, doi. 10.2967/jnumed.116.178889
- By:
- Publication type:
- Article
In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 5, p. 752, doi. 10.2967/jnumed.114.153023
- By:
- Publication type:
- Article
"To Serve and Protect": Enzyme Inhibitors as Radiopeptide Escorts Promote Tumor Targeting.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 1, p. 121, doi. 10.2967/jnumed.113.129411
- By:
- Publication type:
- Article
<sup>99m</sup>Tc Radiotracers Based on Human GRP(18-27): Synthesis and Comparative Evaluation.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 10, p. 1797, doi. 10.2967/jnumed.112.118695
- By:
- Publication type:
- Article
A novel CCK<sub>2</sub>/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study.
- Published in:
- Polish Archives of Internal Medicine, 2018, v. 128, n. 12, p. 791, doi. 10.20452/pamw.4387
- By:
- Publication type:
- Article
Comparative evaluation of the new GRPR‐antagonist <sup>111</sup>In‐SB9 and <sup>111</sup>In‐AMBA in prostate cancer models: Implications of in vivo stability.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 646, doi. 10.1002/jlcr.3733
- By:
- Publication type:
- Article
Theranostic approaches in nuclear oncology: From bench to bed.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 612, doi. 10.1002/jlcr.3787
- By:
- Publication type:
- Article
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, p. 1, doi. 10.1186/s41181-024-00242-6
- By:
- Publication type:
- Article
Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1134, doi. 10.3390/biom13071134
- By:
- Publication type:
- Article
[<sup>111</sup>In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 3, p. 892, doi. 10.1007/s00259-022-05992-6
- By:
- Publication type:
- Article
In memoriam: Marion Hendriks-de Jong.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 12, p. 2856, doi. 10.1007/s00259-020-04776-0
- By:
- Publication type:
- Article
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [Ga]SB3 and PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 5, p. 964, doi. 10.1007/s00259-015-3232-1
- By:
- Publication type:
- Article
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 8, p. 1426, doi. 10.1007/s00259-011-1818-9
- By:
- Publication type:
- Article
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1265, doi. 10.1007/s00259-009-1098-9
- By:
- Publication type:
- Article
[<sup>99m</sup>Tc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 11, p. 1804, doi. 10.1007/s00259-007-0489-z
- By:
- Publication type:
- Article
[<sup>99m</sup>Tc]Demotate 2 in the detection of sst<sub>2</sub>-positive tumours: a preclinical comparison with [<sup>111</sup>In]DOTA-tate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 7, p. 831, doi. 10.1007/s00259-006-0068-8
- By:
- Publication type:
- Article
[sup 99m]Tc-Demotate 1: first data in tumour patients—results of a pilot/phase I study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 9, p. 1211, doi. 10.1007/s00259-003-1225-y
- By:
- Publication type:
- Article
Molecular gastrin receptor localisation in mice using high-resolution SPET-MRI image fusion.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 5, p. 800, doi. 10.1007/s00259-003-1141-1
- By:
- Publication type:
- Article
[[sup 99m] Tc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 2, p. 247, doi. 10.1007/s00259-002-1040-x
- By:
- Publication type:
- Article
Instant kit preparation of <sup>68</sup>Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [<sup>68</sup>Ga]Ga-DATA-TOC.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0516-7
- By:
- Publication type:
- Article
Synthesis and sst<sub>2</sub> binding profiles of new [Tyr<sup>3</sup>]octreotate analogs.
- Published in:
- Journal of Peptide Science, 2008, v. 14, n. 6, p. 725, doi. 10.1002/psc.989
- By:
- Publication type:
- Article
Tetraamine-modified octreotide and octreotate: labeling with <sup>99m</sup>Tc and preclinical comparison in AR4-2J cells and AR4-2J tumor-bearing mice.
- Published in:
- Journal of Peptide Science, 2006, v. 12, n. 2, p. 124, doi. 10.1002/psc.693
- By:
- Publication type:
- Article
Radiolabeled Bombesin Analogs.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5766, doi. 10.3390/cancers13225766
- By:
- Publication type:
- Article
[ 99m Tc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5093, doi. 10.3390/cancers13205093
- By:
- Publication type:
- Article
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
GRP Receptor Imaging of Prostate Cancer Using [Tc]Demobesin 4: a First-in-Man Study.
- Published in:
- Molecular Imaging & Biology, 2014, v. 16, n. 6, p. 888, doi. 10.1007/s11307-014-0754-z
- By:
- Publication type:
- Article